date,title,source
Oct-30-18,"G1 Therapeutics to Provide Third Quarter 2018 Corporate and Financial Update on November 7, 2018",GlobeNewswire
Nov-06-18,G1 Therapeutics to Present at Investor Conferences in November 2018,GlobeNewswire
Nov-07-18,G1 Therapeutics Reports Third Quarter 2018 Financial Results and Corporate Update,GlobeNewswire
Nov-08-18,Edited Transcript of GTHX.O earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-09-18,G1 Therapeutics to Present Preliminary Data from Randomized Phase 2 Trial of Trilaciclib in Metastatic Triple-Negative Breast Cancer at 2018 San Antonio Breast Cancer Symposium (SABCS),GlobeNewswire
Nov-19-18,Edited Transcript of GTHX.O earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-21-18,Edited Transcript of GTHX.O earnings conference call or presentation 7-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-27-18,"The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial",Benzinga
Dec-04-18,Preliminary Results from Randomized Phase 2 Trial Demonstrate Trilaciclib Improved Progression-Free Survival in Combination with Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer,GlobeNewswire
Dec-06-18,"New Research Coverage Highlights G1 THERAPEUTICS, Schlumberger, Adient, Camping World, Nutanix, and CNH Industrial N.V  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Dec-19-18,G1 Therapeutics stock dives on cancer-related infection drug study results,MarketWatch
Dec-19-18,G1 Therapeutics Announces Positive Topline Results from Randomized Phase 2 Trial of Trilaciclib Showing Multi-Lineage Myelopreservation Benefits in 2nd-/3rd-Line Small Cell Lung Cancer,GlobeNewswire
